Clinical trials
Ovarian Reserve clinical trials
Below are recruiting ovarian reserve clinical trials, each written for real people, not researchers. We’re tracking 30 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06626282Recruiting
Fertility after childhood cancer in women
This study looks at how well the ovaries work in women who had childhood cancer. Researchers want to know if cancer treatments affected fertility.
Liège, WalloniaAges 18–50 - NCT05847283Recruiting
Freeze-all IVF approach for low egg reserve
This trial compares two hormone injection protocols to help women with low egg supply grow eggs and collect eggs for IVF. If you qualify, your embryos will be frozen first (“freeze-all”) and then transferred later as one frozen blastocyst.
Hanoi, HanoiAges 18–37 - NCT05790655Recruiting
Platelet-rich ovarian treatment for low egg reserve
This trial tests whether platelet-rich plasma (PRP) can improve fertility outcomes in people with low egg reserve. It may help if you are in the right age range and have been diagnosed with diminished ovarian reserve or poor ovarian response.
New York, New YorkAges 35–42 - NCT07686783Recruiting
Ovary function after cyst removal surgery
This study looks at how ovary function changes after surgery to remove a cyst from the ovary. It compares women with endometriosis-related cysts to those with other types, to better understand recovery.
Banhā, Qalyubia GovernorateAges 18–45 - NCT07511660Enrolling by invitation
Ovarian cell injection for perimenopause symptom relief
This trial tests injecting special cells called Muse cells into the ovaries to help relieve perimenopause symptoms and possibly restore ovarian function. It may help women experiencing irregular periods, hot flashes, sleep problems, mood changes, or trouble thinking clearly.
Monterrey, Nuevo LeónAges 28–70 - NCT06975683Recruiting
PRGF ovarian injection for low ovarian reserve
This study tests a special injection of growth factors from your own blood into the ovary to see if it can improve egg quality and quantity for women with low ovarian reserve. It may be an option if you have been trying to conceive for over a year and have low egg reserve.
MadridAges 18–50 - NCT07124260Recruiting
Gut and tongue bacteria study for low ovarian reserve
This study looks at the bacteria in your gut and on your tongue to see if they are different in women with low ovarian reserve. It may help doctors find new ways to understand and treat this condition.
Hangzhou, ZhejiangAges 20 years+ - NCT07550998RecruitingPhase 3
Yulinzhu herbal treatment for low egg reserve
This trial tests whether a traditional Chinese herbal medicine called Yulinzhu can help women with diminished ovarian reserve (low egg count or quality) improve their chances of pregnancy. The study includes 12 weeks of treatment followed by IVF if you don't conceive naturally.
Hong KongAges 18–40 - NCT07469007Recruiting
How surgery for deep endometriosis affects egg supply
This trial looks at how surgery for deep endometriosis behind the uterus affects a woman's egg supply (ovarian reserve). It is for women with severe deep endometriosis but without large ovarian cysts or previous surgery for this condition.
Quint-FonsegrivesAges 18–39 - NCT07108621RecruitingPhase 3
HCG priming before IVF for low egg reserve
This trial tests whether giving a hormone called hCG before starting IVF can improve outcomes for women with low egg reserve (low AMH). It is designed for women under 40 who are early in their IVF journey.
CopenhagenAges 18–40 - NCT06332742Recruiting
Herbal formula for low egg reserve in women ages 25–45
This trial tests a Chinese herbal formula called Qingxin Zishen Decoction to see if it can improve egg health and hormone levels in women with low ovarian reserve. It may be an option if you are between 25 and 45 and have not had surgery or hormone treatments recently.
Nanjing, JiangsuAges 25–45 - NCT07376824RecruitingPhase 3
Acupoint light therapy and Chinese medicine for ovarian reserve
This trial tests whether combining acupoint photodynamic therapy with traditional Chinese medicine can improve ovarian reserve in women with diminished ovarian reserve. It aims to find a gentle, non-hormonal way to support fertility.
Beijing, Beijing MunicipalityAges 25–40 - NCT06096766Recruiting
Ovarian function and blood markers study
This study looks at how certain blood markers relate to ovarian function in women with normal ovaries, diminished ovarian reserve (DOR), or primary ovarian insufficiency (POI). It may help doctors better understand these conditions.
BeijingAges 18–45 - NCT07535983RecruitingPhase 1/Phase 2
Chinese herbal medicine plus DHEA for low egg reserve
This trial tests whether a traditional Chinese medicine decoction combined with DHEA (a supplement) can improve ovarian function in women with diminished ovarian reserve—a condition where the ovaries produce fewer healthy eggs. The study combines two treatment approaches to see if they work better together.
Nanchang, JiangxiAges 20–40 - NCT07020546Recruiting
Ovarian PRP Injections for Better Embryo Quality
This trial tests whether injecting platelet-rich plasma (PRP) into your ovaries can improve the quality of your embryos. You will go through two IVF cycles, and the treatment aims to help women with low embryo quality get better results.
New York, New YorkAges 18–47 - NCT07246733Recruiting
Royal jelly for ovarian function and uterine lining
This study tests whether a natural substance called royal jelly (a jelly produced by bees) can help improve how well your ovaries work and how your uterus lining responds. If you are a woman of childbearing age with regular periods, this trial may help understand if royal jelly can support fertility.
Yiwu, ZhejiangAges 20–45 - NCT06794047Recruiting
Vitamin C for IVF in women with low ovarian reserve
This study tests whether taking Vitamin C can improve IVF outcomes for women with low ovarian reserve (DOR). If you are starting your first or second IVF cycle and meet certain health criteria, you may be eligible.
Beijing, Beijing MunicipalityAges 20–45 - NCT07685431Recruiting
Alpha-lipoic acid for IVF in women 35-45
This trial tests whether taking alpha-lipoic acid (an antioxidant supplement) before and during IVF can improve pregnancy success in women aged 35–45 using their own eggs. It aims to see if the supplement can help counter age-related declines in egg quality.
Kaohsiung CityAges 35–45 - NCT06426355Recruiting
NMN supplement for IVF in women with low ovarian reserve
This study tests whether a supplement called NMN can improve pregnancy outcomes for women with low ovarian reserve who are undergoing IVF or ICSI. It's designed for women who have been told they have a low egg supply and are looking for options to increase their chances.
Beijing, Beijing MunicipalityAges 20–40 - NCT07039734Recruiting
Ovarian reserve in Fragile X premutation carriers
This study looks at egg supply (ovarian reserve) in women who carry the Fragile X premutation. It aims to understand fertility potential better and help guide future family planning.
Paris, FranceAges 18–40 - NCT04583150Recruiting
Study of fertility and ovarian reserve after weight-loss surgery
This study looks at how ovarian reserve (a fertility-related marker) changes in women after bariatric (weight-loss) surgery versus women with obesity who are not planning surgery. It may help doctors better understand fertility timing and risks around weight-loss treatment.
AngersAges 18–37 - NCT04872660RecruitingPhase 4
Gushen Antai pill to improve IVF ongoing pregnancy rates
This trial studies whether a traditional Chinese medicine pill (Gushen Antai) can improve the chance of an IVF pregnancy that continues (“ongoing pregnancy rate”) and assess its safety. It’s for people starting their first IVF/ICSI cycle with normal ovarian function reserve.
Jinan, ShandongAges 21–42 - NCT05429138Recruiting
Tracking egg and sperm changes during melanoma treatment
This study measures how anti-cancer treatment affects a person’s egg reserve (for women) or semen quality (for men) over time. It may help doctors better understand fertility-related side effects of melanoma therapy and how they evolve during routine treatment.
BordeauxAges 18–45 - NCT05754593Recruiting
Study ovarian reserve in women with multiple sclerosis
This study compares egg supply (“ovarian reserve”) in women with multiple sclerosis to women without MS. It may help doctors understand how MS affects reproductive health and egg supply.
BordeauxAges 25–35
Hear when a new Ovarian Reserve trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ovarian reserve?
- Yes. Clin2 currently lists 30 recruiting ovarian reserve studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ovarian reserve trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ovarian reserve trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.